摘要
近年来,预测急性冠脉综合征预后的研究相继开展,传统的生物标志物具有良好的预测价值,新型生物标志物从各个生物机制角度出发提高了预测特异性,多维度的评分量表同样在危险分层及预后预测方面具有价值。发展新型生物标志物及改良评分量表值得进一步探索。
In recent years, studies have been developed for predicting the prognosis of acute coronary syndrome. Traditional biomarkers have been proven to be of good predictive value. The new biomarkers increase the predictive specificity from represented various biological mechanisms. As well, multi-dimension risk scores were good for prognosis prediction and risk stratification. The development of new biomarkers and improvement scoring scales is worth exploring.
作者
高文君
韩明华
GAO Wenjun;HAN Minghua(Kunming Medical University Graduate School,Kunming 650000,Yunnan,China;Department of Cardiology,The Fourth Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan,China)
出处
《心血管病学进展》
CAS
2018年第4期606-610,共5页
Advances in Cardiovascular Diseases
